Oxyphil cells in primary hyperparathyroidism: a clinicopathological study.
Oxyphil cells
Parathyroid gland
Primary hyperparathyroidism
Journal
Hormones (Athens, Greece)
ISSN: 2520-8721
Titre abrégé: Hormones (Athens)
Pays: Switzerland
ID NLM: 101142469
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
received:
10
02
2021
accepted:
18
06
2021
pubmed:
7
7
2021
medline:
1
3
2022
entrez:
6
7
2021
Statut:
ppublish
Résumé
The role of oxyphil cells (OxC) in primary hyperparathyroidism (PHPT) still remains controversial. Historically, they were believed to be involuted cells. However, they could play an important role in hormone secretion. The clinical behavior of OxC-rich adenomas and preoperative PHPT localization tests have been widely studied. The aim of this study is to analyze the implications of OxC in PHTP. A retrospective cohort study of patients undergoing parathyroidectomy for PHPT was conducted. Additionally, we included normal glands removed in the context of PHPT or inadvertently during a thyroidectomy. All glands were reviewed independently by three researchers, performing a semi-quantitative analysis of the percentage of OxC. Groups with < 25% OxC and > 75% OxC were compared. In the period 2010-2017, 238 patients and 261 removed glands were included (8.8% OxCA > 75%). There were no differences in symptomatology and levels of preoperative calcium, parathormone, or 25-OH vitamin. Patients with OxCA > 75% had worse preoperative glomerular filtration rate (81.2 vs. 69.7 mL/min/1.73 m Our study suggests that phosphocalcic metabolism is not influenced by the presence of a high content of OxC in the parathyroid glands. A high content of OxC seems to be exclusive to pathologic glands and could be related to the deterioration of renal function in patients with PHPT.
Sections du résumé
BACKGROUND
BACKGROUND
The role of oxyphil cells (OxC) in primary hyperparathyroidism (PHPT) still remains controversial. Historically, they were believed to be involuted cells. However, they could play an important role in hormone secretion. The clinical behavior of OxC-rich adenomas and preoperative PHPT localization tests have been widely studied. The aim of this study is to analyze the implications of OxC in PHTP.
METHODS
METHODS
A retrospective cohort study of patients undergoing parathyroidectomy for PHPT was conducted. Additionally, we included normal glands removed in the context of PHPT or inadvertently during a thyroidectomy. All glands were reviewed independently by three researchers, performing a semi-quantitative analysis of the percentage of OxC. Groups with < 25% OxC and > 75% OxC were compared.
RESULTS
RESULTS
In the period 2010-2017, 238 patients and 261 removed glands were included (8.8% OxCA > 75%). There were no differences in symptomatology and levels of preoperative calcium, parathormone, or 25-OH vitamin. Patients with OxCA > 75% had worse preoperative glomerular filtration rate (81.2 vs. 69.7 mL/min/1.73 m
CONCLUSIONS
CONCLUSIONS
Our study suggests that phosphocalcic metabolism is not influenced by the presence of a high content of OxC in the parathyroid glands. A high content of OxC seems to be exclusive to pathologic glands and could be related to the deterioration of renal function in patients with PHPT.
Identifiants
pubmed: 34228313
doi: 10.1007/s42000-021-00305-2
pii: 10.1007/s42000-021-00305-2
doi:
Substances chimiques
Parathyroid Hormone
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
715-721Informations de copyright
© 2021. Hellenic Endocrine Society.
Références
Wilhelm SM, Wang TS, Ruan DT, Lee JA, Asa SL, Duh QY et al (2016) The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg 151(10):959–968
doi: 10.1001/jamasurg.2016.2310
Welsh DA (1898) Concerning the parathyroid glands: a critical anatomical and experimental study. J Anat Physiol 32:380-402.1
pubmed: 17232318
pmcid: 1327899
Castleman B, Mallory TB (1935) The pathology of the parathyroid gland in hyperparathyroidism. Am J Pathol 11:1–72
pubmed: 19970186
pmcid: 1910762
McGregor DH, Lotuaco LG, Rao MS, Chu LL (1978) Functioning oxyphil adenoma of parathyroid gland. An ultrastructural and biochemical study. Am J Pathol 92(3):691–711
pubmed: 686153
pmcid: 2018274
Christie AC (1967) The parathyroid oxyphil cells. J clin Path 20:591
doi: 10.1136/jcp.20.4.591
Tremblay G, Cartier GE (1961) Histochemical study of oxidative enzymes in the human parathyroid. Endocrinol 69:658–61
doi: 10.1210/endo-69-3-658
Allen TB, Thorburn KM (1981) The oxyphil cell in abnormal parathyroid glands. Arch Pathol Lab Med 105:421–427
pubmed: 6894851
Ritter CS, Haughey BH, Miller B, Brown AJ (2012) Differential gene expression by oxyphil and chief cells of human parathyroid glands. J Clin Endocrinol Metab 97(8):1499–1505
doi: 10.1210/jc.2011-3366
Howson P, Kruijff S, Aniss A, Pennington T, Gill AJ, Dodds T et al (2015) Oxyphil cell parathyroid adenomas causing primary hyperparathyroidism: a clinico-pathological correlation. Endocr Pathol 26(3):250–254
doi: 10.1007/s12022-015-9378-3
Sandrock D, Merino MJ, Norton JA, Neumann RD (1993) Ultrastructural histology correlates with results of thallium-201/technetium-99m parathyroid subtraction scintigraphy. J Nucl Med 34(1):24–29
pubmed: 8418265
Carpentier A, Jeannotte S, Verreault J, Lefebvre B, Bisson G, Mongeau CJ et al (1998) Preoperative localization of parathyroid lesions in hyperparathyroidism: relationship between technetium-99m-MIBI uptake and oxyphil cell content. J Nucl Med 39(8):1441–1444
pubmed: 9708524
Erbil Y, Kapran Y, Işsever H, Barbaros U, Adalet I, Dizdaroǧlu F et al (2008) The positive effect of adenoma weight and oxyphil cell content on preoperative localization with 99mTc-sestamibi scanning for primary hyperparathyroidism. Am J Surg 195(1):34–39
doi: 10.1016/j.amjsurg.2007.01.040
Takebayashi S, Hidai H, Chiba T, Takagi Y, Nagatani Y, Matsubara S (1999) Hyperfunctional parathyroid glands with 99mTc-MIBI scan: semiquantitative analysis correlated with histologic findings. J Nucl Med 40(11):1792–1797
pubmed: 10565772
Staudenherz A, Abela C, Niederle B, Steiner E, Helbich T, Puig S et al (1997) Comparison and histopathological correlation of three parathyroid imaging methods in a population with a high prevalence of concomitant thyroid diseases. Eur J Nucl Med 24(2):143–149
doi: 10.1007/BF02439546
Bedetti CD, Dekker A, Watson CG (1984) Functioning oxyphil cell adenoma of the parathyroid gland: a clinicopathologic study of ten patients with hyperparathyroidism. Hum Pathol 15(12):1121–6. https://doi.org/10.1016/S0046-8177(84)80306-8
doi: 10.1016/S0046-8177(84)80306-8
pubmed: 6389314
Wolpert HR, Vickery AL, Wang CA (1989) Functioning oxyphil adenomas. Am J Surg Pathol 13(6):500–504
doi: 10.1097/00000478-198906000-00006
Mehta NY, Ruda JM, Kapadia S, Boyer PJ, Hollenbeak CS, Stack BC (2005) Relationship of technetium Tc 99m sestamibi scans to histopathological features of hyperfunctioning parathyroid tissue. Arch Otolaryngol - Head Neck Surg 131(6):493–498
doi: 10.1001/archotol.131.6.493
Mihai R, Gleeson F, Buley ID, Roskell DE, Sadler GP (2006) Negative imaging studies for primary hyperparathyroidism are unavoidable: correlation of sestamibi and high-resolution ultrasound scanning with histological analysis in 150 patients. World J Surg 30(5):697–704
doi: 10.1007/s00268-005-0338-9
Ritter CS, Haughey BH, Armbrecht HJ, Brown AJ (2012) Distribution and regulation of the 25-hydroxyvitamin D 3 1α-hydroxylase in human parathyroid glands. J Steroid Biochem Mol Biol 130(1–2):73–80. https://doi.org/10.1016/j.jsbmb.2012.01.010
doi: 10.1016/j.jsbmb.2012.01.010
pubmed: 22326730
Westreich RW, Brandwein M, Mechanick JI, Bergman DA, Urken ML (2003) Preoperative parathyroid localization: correlating false-negative technetium 99m sestamibi scans with parathyroid disease. Laryngoscope 113(3):567–572
doi: 10.1097/00005537-200303000-00032
Ishibashi M, Nishida H, Strauss HW, Kojima K, Fujito H, Watanabe J (1997) Localization of parathyroid glands using technetium-99m-tetrofosmin imaging. J Nucl Med 38(5):706–711
pubmed: 9170432
Melloul M, Paz A, Koren R, Cytron S, Feinmesser R, Gal R (2001) 99mTc-MIBI scintigraphy of parathyroid adenomas and its relation to tumour size and oxyphil cell abundance. Eur J Nucl Med 28(2):209–213
doi: 10.1007/s002590000406
Bleier BS, LiVolsi VA, Chalian AA, Gimotty PA, Botbyl JD, Weber RS (2006) Technetium Tc 99m sestamibi sensitivity in oxyphil cell-dominant parathyroid adenomas. Arch Otolaryngol - Head Neck Surg 132(7):779–782
doi: 10.1001/archotol.132.7.779
Stephen AE, Roth SI, Fardo DW, Finkelstein DM, Randolph GW, Gaz RD et al (2007) Predictors of an accurate preoperative sestamibi scan for single-gland parathyroid adenomas. Arch Surg 142(4):381–386
doi: 10.1001/archsurg.142.4.381
Ugur O, Bozkurt MF, Hamaloglu E, Sokmensuer C, Etikan I, Ugur Y et al (2004) Clinicopathologic and radiopharmacokinetic factors affecting gamma probe-guided parathyroidectomy. Arch Surg 139(11):1175–1179
doi: 10.1001/archsurg.139.11.1175
Cermik TF, Puyan FO, Sezer A, Firat MF, Berkarda S (2005) Relation between Tc-99m sestamibi uptake and biological factors in hyperparathyroidism. Ann Nucl Med 19(5):387–392
doi: 10.1007/BF03027403
Dugonjić S, Cerović S, Janković Z, Ajdinović B (2012) Korelacija nalaza suptrakcione scintigrafije paratiroidnih žlezda liposolubilnim radiofarmacima sa veličinom, patohistološkim nalazom i procentom oksifilnih ćelija kod bolesnika sa hiperplazijom paratiroidnih žlezda. Vojnosanit Pregl 69(4):345–352
doi: 10.2298/VSP1204345D
Lundgren E, Ridefelt P, Åkerström G, Ljunghall S, Rastad J (1996) Parathyroid tissue in normocalcemic and hypercalcemic primary hyperparathyroidism recruited by health screening. World J Surg 20(7):727–735
doi: 10.1007/s002689900111